Synergistic eŠects have previously been observed for a natural compound, tetrandrine (TET), with ‰uconazole (FLC) in vitro and in the treatment of Candida albicans-infected mice. To investigate the mechanisms of these synergistic eŠects, 16 strains of C. albicans from the same parent but with diŠerent FLC sensitivities were examined using ‰ow cytometry and ‰uorescent spectrophotometry. Rhodamine 123 (Rh123)-positive cells and intracellular Rh123 ‰uores-cence intensity were determined in accumulation/eOEux experiments involving no or a noncytotoxic dose of TET. Total RNA extracted from each strain was used to compare the expressions of drug eOEux pump genes in FLC-susceptible, -susceptible dose-dependent, and -resistant strains before and 24 h after TET administration. Accumulation experiments determined that mean percentages of Rh123-positive cells were 26.65％ (TET-free) and 70.99％ (TET 30 mg/ml), and mean respective intracellular Rh123 ‰uorescence intensities were 11.34 and 18.00. EOEux experiments showed that percentages of Rh123-positive cells were 1.79％ (TET free) and 42.57％ (TET 30 mg/ml), respectively, and respective mean intracellular Rh123 ‰uorescence intensities were 0.74 and 2.19. DiŠerences in MDR1, FLU1, CDR1, and CDR2 expression levels in the absence of TET were statistically signiˆcant ( p＜0.05) between FLC-susceptible, -susceptible dosedependent, and -resistant strains. Compared with TET-free conditions, 24 h TET-treated strains showed statistically diŠerent ( p＜0.05) expression of MDR1 (FLC-resistant strain), FLU1 (FLC-susceptible dose-dependent and -resistant strains), and CDR1 and CDR2 (FLC-susceptible, -susceptible dose-dependent, and -resistant strains). Thus TET can inhibit the C. albicans drug eOEux system and reduce drug eOEux. Its mechanism of action is related to the inhibition of expression of the drug eOEux pump genes MDR1, FLU1, CDR1, and CDR2.
INTRODUCTION
Candida albicans is a common opportunistic fungus seen in humans, which can cause cutaneous, mucosal, subcutaneous, and systemic infections. Fluconazole (FLC) is aˆrst-line drug in the treatment of candidiasis, 1, 2) but drug resistance is increasingly being observed. 3, 4) Overexpression of the cell membrane drug eOEux pump genes MDR1, FLU1, CDR1, and CDR2, 3 13) and alterations in the target gene ERG11 14) are the main mechanisms of azole drug resistance in C. albicans. Therefore drug eOEux pump inhibitors are being sought as a method of reversing drug resistance in this organism.
In recent years, a number of studies have addressed this issue. 15 24) Drugs such as tacrolimus 22) and cyclosporine 18, 19) can reverse CDR-mediated C. albicans FLC and ketoconazole resistance in vitro by inhibiting Cdr1p and Cdr2p, but because these drugs have signiˆcant cardio-and nephrotoxicity, their clinical applicability is low. Tetrandrine (TET) is a low-toxicity drug extracted from the plant Stephania tetrandra S. Moore (or Fenfangji) of the Menispermaceae family. Our preliminary research demonstrated that TET can increase the sensitivity of C. albicans to FLC in vitro at noncytotoxic doses, 25) and that the compound acts synergistically with FLC in the treatment of C. albicans-induced vaginitis in mice. 26) The present study utilized ‰ow cytometry and ‰uorescent spectrophotometry to evaluate the eŠects of TET on the C. albicans drug eOEux system, while also using the semiquantitative reverse-transcriptase-polymerase chain reaction (RT-PCR) to examine MDR1, FLU1, CDR1, and CDR2 mRNA levels to determine the molecular mechanism of action of TET.
MATERIALS AND METHODS

Strains
A series of 16 clinical isolates of C. albicans (CA 1, CA 2, ......, CA 17, CA 10 was not available; generously provided by Theodore C. White, University of Washington, and the Seattle Biomedical Research Institute, USA) from a HIV-infected male who was treated with increasing doses of FLC. The MICs for this series of isolates from the patient increased at intervals, starting with an MIC of 0.25 mg/ml and eventually rising to an MIC greater than 64 mg/ml. They were susceptible (CA 1, CA 2, ......, CA 12), susceptible dose-dependent (CA 13, CA 14, CA 15), and resistant (CA 16, CA 17) to FLC. Several techniques were used to demonstrate that the isolates from this series were the same strain of C. albicans. The resistance phenotype of theˆnal isolate (isolate CA 16, CA 17) is genetically stable, as it persists for more than 600 generations in the absence of azoles.
Culture Media YEPD agar slant, YEPD broth, and RPMI-1640 broth (with or without 10％ bovine serum) were prepared as described in the CLSI M27-A protocol. 27) Flow Cytometry Flow cytometry was utilized to determine the percentage of Rh123-positive cells in the 16 C. albicans strains before and after TET (Huico Plant Co. Ltd., Shanxi, China; purity 99.6 ％) administration and after previously detailed accumulation / eOEux experiments. 28, 29) During the logarithmic growth phase, recovered C. albicans was suspended in 4 ml of sorbitol solution at a density of 5 ×10 6 cells/ml. Sixty units of lyticase (Sigma, St. Louis, MO, USA) and 50 ml of b-mercaptoethanol were added, and the suspension was incubated at 37°C for 2 h. Precooled (4°C) phosphate-buŠered saline (PBS) was used to wash the cells twice (cells and supernatant were separated by centrifugation at 744×g for 5 min). Processed cells were resuspended in 3 ml of RPMI-1640 broth and divided into three equal volumes (A, B, and C) in separate test tubes. Rh123 was added to tubes A and B at aˆnal concentration of 2 mg/ml. TET was additionally added to tube B at â nal concentration of 30 mg/ml. This dose has been shown to be noncytotoxic. 25) No drugs were added to tube C. The tubes were incubated at 37°C for 45 min, washed twice with precooled PBS, and 500 ml was used for accumulation experiments. RPMI-1640 broth was added to the remaining suspensions in tubes A and B, and TET was again added to tube B at the sameˆnal concentration. The tubes were incubated at 37°C for 45 min, washed twice with precooled PBS, and 500 ml was used for eOEux experiments. Samples were examined using ‰ow cytometry, and 10000 cells were counted in the ‰uorescein isothiocyanate (FITC) channel (l excitation ＝488 nm, l emission ＝530 nm) to construct single-parameter histograms. Data were processed with Cellques software, and the percentages of Rh123-positive cells were calculated. Fluorescent Spectrophotometry Intracellular Rh123 ‰uorescence intensities before and after TET administration and after accumulation/eOEux experiments 28) were determined using ‰uorescent spectrophtometry. Sample preparation was performed as described above. The samples were diluted with PBS to aˆnal volume of 3 ml, and sample ‰uorescence intensities were measured using ‰uorescent spectrophotometry (l excitation ＝488 nm, l emission ＝530 nm). Ultraviolet spectrophotometry was used to determine sample intracellular OD 600 values, and intracellular Rh123 ‰orescence intensities were calculated.
Extraction of Total C. albicans RNA Extraction was performed as previously described. 5, 6) Activated C. albicans was inoculated in RPMI-1640 broth containing no TET or TET 30 mg/ml, incubated at 30°C for 24 h, and the cells were collected by centrifugation. One milliliter of Trizol RNA reagent (Invitrogen, CA, USA) was added and used to disperse each cell pellet thoroughly. After complete homogenization, the sample was incubated at room temperature for 5 min. Two hundred microliters of chloroform was added, vortexed vigorously for 15 s, and the sample was then incubated at room temperature for 2 min. The sample was centrifuged at 11913×g and 4°C for 15 min. The supernatant was obtained, an equal volume of isopropanol was added, and the sample was incubated at room temperature for 10 min after mixing. The sample was centrifuged at 11913×g and 4°C for 10 min. The supernatant was discarded, and ethanol 1 ml was added prior to a 30 s period of vortexing. The sample was centrifuged at 4653×g and 4°C for 5 min. The supernatant was discarded, and the cells were dried before being resuspended in diethylpyrocarbonate (DEPC)-treated water and stored for 
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later use. RNA sample quality was determined with 1.2％ agarose gel electrophoresis as described previously. 5) cDNA Synthesis cDNA was synthesized as described previously. 6) The reaction volume of 20 ml consisted of Oligo(dt) 18 primer 1 ml (Shanghai Sangon Biological Engineering Technology & Services Co., Ltd., Shanghai, China), total RNA 2 ml, RNasin (Toyobo, Osaka, Japan) 0.5 ml, dNTPs 1 ml, 10× reaction buŠer 2 ml, and MMLV (Toyobo, Osaka, Japan) 1 ml, with the remaining volume composed of RNase-free water. The reaction temperatures were 37°C for 90 min, 95°C for 10 min, and reaction termination temperature of 4°C. Samples were stored at -70°C until use. PCR and Product Veriˆcation Analysis Target gene and internal reference gene (18S rRNA) primer sequences and annealing temperatures are shown in Table 1 . The total reaction volume of 25 ml consisted of cDNA 2 ml from a single strain, target gene upstream primer 1 ml, target gene downstream primer 1 ml, dNTPs 1 ml, Taq DNA polymerase 0.5 ml (Shanghai Sangon Biological Engineering Technology & Services), 10×reaction buŠer 2.5 ml, and sterile double-distilled water 16 ml. The reaction conditions were 94°C for 3 min, 30 cycles of 94°C for 40 s, the appropriate annealing temperature (see Table 1 ) for 30 s, and 72°C for 30 s, followed by 72°C for 10 min. Five microliters of PCR product was obtained for 2％ agarose gel electrophoresis. After ethidium bromide staining, a gel electrophoresis imaging analysis system was used to perform gray value analysis for the amplied fragments. MDR1/18S rRNA, FLU1/18S rRNA, CDR1/18S rRNA, and CDR2/18S rRNA ratios were used to represent the relative expression levels of MDR1, FLU1, CDR1, and CDR2, respectively.
Statistical Analyses
All experiments were performed three times, and the mean values were recorded asˆnal results. SPSS 11.5 software was used for analysis, and the results are expressed as the mean± S.D. In the accumulation/eOEux experiments, changes in the percentage of Rh123-positive C. albicans cells were analyzed using the x 2 test. Changes in intracellular Rh123 ‰uorescence intensity and comparisons of drug eOEux pump gene expression levels before and after TET administration were analyzed using the paired t-test. In the TET-free case, comparisons of drug eOEux pump gene expression level between strains with diŠerent FLC sensitivities (susceptible, susceptible dose-dependent, and resistant) were performed using one-way analysis of variance (ANO-VA). Statistical signiˆcance was deˆned as p＜0.05.
RESULTS
EŠects of TET on C. albicans Rh123 Accumulation and EOEux, as Determined by Flow Cytometry
For each of the 16 C. albicans strains, 10000 cells were counted using ‰ow cytometry in the FITC channel to construct a single-parameter histogram. The results for strains CA 3 and CA 4 are shown in Fig.  1 . The mean percentages of Rh123 positive cells 24 h after the accumulation experiments were 26.65％
(TET free) and 70.99％ (TET 30 mg/ml) (x 2 ＝ 62948, p＝0.000). In the eOEux experiments, the percentages were 1.79％ (TET free) and 42.57％ (TET 30 mg/ml) ( Fig. 2; x 2 ＝77078, p＝0.000). The mean intracellular Rh123 ‰uorescence intensities for the 16 C. albicans strains 24 h after the accumulation experiments were 11.34
(TET free) and 18.00 (TET 30 mg/ml), respectively. The diŠerence was statistically signiˆcant (t＝ -2.506, p＝0.024). After the eOEux experiments, the intensities were 0.74 (TET free) and 2.19 (TET 30 mg /ml), which was also a statistical diŠerence (t＝ -5.428, p＝0.000). This indicates that TET can decrease C. albicans Rh123 eOEux and increase intracellular Rh123 accumulation ( Table 2) .
Analysis of MDR1, FLU1, CDR1, and CDR2 RT PCR Products before and 24 h after TET Administration Extracted total C. albicans RNA was examined under ultraviolet light after undergoing 1.2％ agarose gel electrophoresis. Three clear, complete electrophoresis bands corresponding to the 5.8S, 18S, and 28S subunits were evident. A1 is the TET free strains after the accumulation experiments, B1 is the TET 30 mg/ml strains after the accumulation experiments, A2 is the TET free strains after the eOEux experiments, and B2 is the TET 30 mg/ml strains after the eOEux experiments. C is background control, A1 is the TET free accumulation experimental result, A2 is the TET free eOEux experimental result, B1 is the TET 30 mg/ ml accumulation experimental result, and B2 is the TET 30 mg/ml eOEux experimental result. Background was subtracted during calculations (OD 600 ＝0.1).
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No. 5 RT-PCR product semiquantitative analysis was also conducted using the internal reference gene (18S rRNA) as a standard. Target gene (MDR1, FLU1, CDR1, and CDR2) mRNA levels were quantiˆed in relation to the standard for each of the 16 C. albicans strains. The results are shown in Table 3 . In the TET free case, expression level diŠerences for the above target genes between the FLC-susceptible, -susceptible dose-dependent, and -resistant strains were statistically signiˆcant (p＜0.05). In the susceptible dose-dependent and resistant strains, MDR1, FLU1, CDR1, and CDR2 mRNA expression levels were higher than in the susceptible strains. In the TET free and TET 30 mg/ml cases, expression levels of each C. albicans target gene were compared 24 h after treatment. For MDR1, the diŠerence in the FLC-resistant strain was statistically signiˆcant ( p＜0.05). Its expression level decreased after TET administration, but the diŠerences in the susceptible strain and the susceptible dose-dependent strain were not statistically signiˆcant ( p＞0.05). For FLU1, the diŠerences between the susceptible dose-dependent strain and the resistant strain were statistically signiˆcant ( p＜ 0.05). Its expression level decreased after TET administration, but the diŠerence in the susceptible strain was not statistically signiˆcant ( p＞0.05). For CDR1 and CDR2, the diŠerences among the susceptible strain, susceptible dose-dependent strain, and resistant strain were all statistically signiˆcant ( p＜ 0.05), and their expression levels decreased after TET administration ( Table 3) .
DISCUSSION
We previously reported in that TET synergistically increases the candidacidal activity of TET in vitro 25) and in vivo. 26) Microdilution experiments showed that, with FLC alone, the MIC values for the 16 C. albicans strains were 0.250 64 mg/ml. With TET 40 mg/ ml, FLC MIC values for the test organisms decreased to 0.125 16 mg/ml. Furthermore, the endpoints were clear, and no``tailing'' phenomenon was observed. 25) In a mouse model of C. albicans vaginitis, TET and FLC in diŠerent dose combinations were administered vaginally once daily from day 3 onward for 7 days. The results showed that, up to day 11, the fungal load of the group given TET 26 mg/kg/day and FLC 26 mg/kg/day was signiˆcantly lower compared with the group given FLC 26 mg/kg/day alone. Compared with the other groups, microscopic examination of vaginal smears showed no pseudohyphae in the TET 26 mg/kg/day＋FLC 26 mg/kg/day group mice, but varying amounts of pseudohyphae and pseudohyphae aggregates were seen in the other groups. Pathologic examination of vaginal tissues showed that in the TET 26 mg/kg/day＋FLC 26 mg/ kg/day group, mucosal edema was slight with minimal in‰ammatory cell inˆltration, and no pseudohyphae were found within vaginal cavities and mucosal layers. 26) The main molecular mechanisms of azole drug resistance in C. albicans are most often overexpression of eOEux pumps 3, 6, 7) and mutation-mediated overexpression of genes that code for proteins targeted by azole drugs. 14) Two types of eOEux pump system are active in the drug-resistance process. Theˆrst involves ATP-binding cassette transporters (ABC, coded by CDR genes), which are ATP-dependent active transporters. 10, 11) In C. albicans, eOEux pumps in the ABC superfamily include Cdr1p and Cdr2p, coded by CDR1 and CDR2, respectively. 8,9,11) EOEux pumps belonging to this superfamily are ubiquitously present and structurally similar in organisms ranging from prokaryotic cells to mammals. 30) In mammalian cells, they are present mainly in the form of the transmembrane protein P-gp (coded by MDR1), 31, 32) and in fungi they are mainly multidrug-resistance proteins (MRPs, mainly Cdrp). 11) In addition to their major function of extruding harmful material from the cell, upregulation of their activity is intimately related to antiparasitic resistance in parasites and chemotherapy resistance in tumors. 30) The second type of eOEux pump is the major facilitator superfamily (MFS, coded by MDR genes), which are electrochemical gradient-dependent passive transporters. In C. albicans, they include CaMdr1p and Flu1p, coded by CaMDR1 16) and FLU1, 5) respectively. A molecular epidemiologic study of C. albicans FLC resistance showed that 83％ of drug resistance is related to CDR1 overexpression, and 67％ is related to CaMDR1 overexpression. 3) Rh123 is a cationic dye with a high ‰uorescence quantum yield and no cytotoxicity. It is generally believed that Rh123 enters cells by diŠusion before being pumped out of cells by eOEux pumps of the ABC superfamily. 28) It is the substrate of many MDR eOEux pumps including Cdr1p and Cdr2p and can be used to evaluate eOEux function in tumor cells such as those possessing P-gp. 28, 29) We compared the percentages of Rh123-postive cells and intracellular Rh123 ‰uorescence intensities in C. albicans strains before and after TET administration to evaluate the eŠects of TET on drug eOEux pump function (such as Cdr1p and Cdr2p). Our results from accumulation/eOEux experiments demonstrated that the mean percentages of Rh123-positive cells and mean intracellular Rh123 ‰uorescence intensities in the 16 C. albicans strains exposed to noncytotoxic doses of TET were signiˆcantly higher than in the unexposed strains. These observations indicate that TET can inhibit the drug eOEux pump function in C. albicans, decreasing drug eOEux activity and hence increasing intracellular Rh123 accumulation. The RT-PCR results showed that prior to TET administration mRNA expression levels of the drug eOEux pump genes MDR1, FLU1, CDR1, and CDR2 in the susceptible dose-dependent strain and the resistant strain were signiˆcantly higher than in the susceptible strain. Twenty-four hours after the administration of noncytotoxic doses of TET, the expression levels of MDR1 (resistant strain), FLU1
(susceptible dose-dependent strain and resistant strain), CDR1 (susceptible strain, susceptible dosedependent strain, and resistant strain), and CDR2 ( susceptible strain, susceptible dose-dependent strain, and resistant strain) all signiˆcantly decreased compared with those before TET administration. This indicates that, in terms of mRNA levels, the mechanism of the synergistic eŠect of TET on the candidacidal activity of FLC is related to the inhibition of the genes coding for the drug eOEux pumps. It was also found that, among diŠerent strains (even strains with the same MIC), MDR1, FLU1, CDR1, and CDR2 expression levels were not completely identical. After TET administration, the mean expression levels of each target gene mRNA were also downregulated to diŠerent degrees, suggesting the possible existence of other mechanisms in addition to the four eOEux pumps described above, or a situation in which the mRNA expression level is not directly indicative of eOEux pump function. It can be seen from the present results that the mechanism of TET in reversing C. albicans FLC resistance is similar to its mechanism in reversing chemotherapy resistance in human tumor cells.
RT-PCR has the advantages of simplicity, high sensitivity, and high e‹cacy, making it suitable for detecting multiple genes in large samples. Our study performed three parallel experiments under identical conditions and implemented corrections using the housekeeping gene (18S rRNA) as the internal reference gene, thereby increasing quantiˆcation accuracy.
TET is a bis-benzylisoquinoline alkaloid, which is the main active component in the root of S. tetrandra S. Moore (or Fenfangji) of the Menispermaceae family. 33) TET has been used in the treatment of hypertension, cardiac arrhythmia, and angina pectoris in China since the 1950s 33, 34) and few side eŠects have been noted in clinical practice. TET has been shown to be a Ca 2＋ channel antagonist and to interact with the voltage-activated L-type and T-type Ca 2＋ channels and the slowly gating K (Ca) channel with varying degrees of speciˆcity and a‹nity. 33) Recent studies have shown that TET has a reversal eŠect on P-gp-mediated MDR. 32, 35) In preliminary screening, TET was shown to be more potent than other herbs in modulating MDR in vitro. 34) The C. albicans drug eOEux pumps Cdr1p and Cdr2p are highly homologous to P-gp and have similar structures and functions. 30) Cdr1p and Cdr2p are also intimately related to C. albicans FLC drug resistance. 9, 11) The present study showed that TET can increase the candidacidal activity of FLC by decreasing Cdr1p and Cdr2p FLC eOEux.
In summary, tetrandrine, a Chinese herb extract, has no intrinsic antifungal activity against C. albicans at concentrations of less than 40 mg/ml but is a potent synergist in combination with FLC in vitro and in vivo. The main mechanism of action of TET may be to reverse CDR1, CDR2, MDR1, and FLU1 associated with an increase in the intracellular azole accumulation by inhibiting the overexpression of MRP, CaMdr1p, and Flu1p and may interact directly with multidrug eOEux transporters present in C. albicans. Thus, by inhibiting their activity, this drug could increase the susceptibility of C. albicans to azoles. Clearly, the eŠects of TET in combination with azoles needs to be more thoroughly investigated. This new concept of combining FLC, and perhaps other azoles, with TET or with its analogue compounds might open a new therapeutic approach for the management of fungal infections.
